immatics biotechnologies GmbH
Utility Patents

Last updated:

List of all immatics biotechnologies GmbH patents 366 in total

Status Patent
Grant
Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: T cell receptors and immune therapy using the same against prame positive cancers External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 13 Oct 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Immunotherapy against several tumors, such as lung cancer, including NSCLC External link
Filling date: 9 Sep 2025 Issue date: 6 Oct 2020
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 22 Sep 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various cancers External link
Filling date: 9 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 8 Sep 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 4 Aug 2020
Grant
Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) External link
Filling date: 9 Sep 2025 Issue date: 4 Aug 2020
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against various tumors External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 9 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers External link
Filling date: 9 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Immunotherapy against neuronal and brain tumors External link
Filling date: 9 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers External link
Filling date: 9 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers External link
Filling date: 9 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers External link
Filling date: 9 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: T cell receptors and immune therapy using the same External link
Filling date: 9 Sep 2025 Issue date: 7 Jul 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Method of treating with a peptide External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers External link
Filling date: 9 Sep 2025 Issue date: 23 Jun 2020

Showing 200 to 250 of 366 patents.